Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Efficacy of Lu AA21004 on Cognitive Dysfunction in Major Depressive Disorder

ClinicalTrials.gov ID: NCT01564862

Public ClinicalTrials.gov record NCT01564862. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 11:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Active-Referenced, Flexible Dose Study on the Efficacy of Lu AA21004 on Cognitive Dysfunction in Adult Subjects With Major Depressive Disorder (MDD)

Study identification

NCT ID
NCT01564862
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Takeda
Industry
Enrollment
602 participants

Conditions and interventions

Interventions

  • Duloxetine Drug
  • Placebo Drug
  • vortioxetine (Lu AA21004) Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2012
Primary completion
Jan 31, 2014
Completion
Jan 31, 2014
Last update posted
Feb 4, 2015

2012 – 2014

United States locations

U.S. sites
62
U.S. states
26
U.S. cities
62
Facility City State ZIP Site status
Not listed Tucson Arizona
Not listed Little Rock Arkansas
Not listed Bellflower California
Not listed Carson California
Not listed Cerritos California
Not listed Glendale California
Not listed Imperial California
Not listed Los Angeles California
Not listed Norwalk California
Not listed Oakland California
Not listed Paramount California
Not listed San Bernardino California
Not listed Santa Ana California
Not listed Wildomar California
Not listed Colorado Springs Colorado
Not listed Denver Colorado
Not listed Norwalk Connecticut
Not listed Lauderhill Florida
Not listed Miami Florida
Not listed Orlando Florida
Not listed Sanford Florida
Not listed St. Petersburg Florida
Not listed Tampa Florida
Not listed West Palm Beach Florida
Not listed Chicago Illinois
Not listed Hoffman Estates Illinois
Not listed Naperville Illinois
Not listed Oak Brook Illinois
Not listed Skokie Illinois
Not listed Indianapolis Indiana
Not listed Prairie Village Kansas
Not listed Shreveport Louisiana
Not listed Baltimore Maryland
Not listed Haverhill Massachusetts
Not listed St Louis Missouri
Not listed North Platte Nebraska
Not listed Las Vegas Nevada
Not listed Buffalo New York
Not listed New York New York
Not listed Staten Island New York
Not listed Avon Lake Ohio
Not listed Beachwood Ohio
Not listed Garfield Heights Ohio
Not listed Toledo Ohio
Not listed Oklahoma City Oklahoma
Not listed Portland Oregon
Not listed Allentown Pennsylvania
Not listed Norristown Pennsylvania
Not listed Philadelphia Pennsylvania
Not listed Columbia South Carolina
Not listed Franklin Tennessee
Not listed Memphis Tennessee
Not listed Dallas Texas
Not listed Houston Texas
Not listed San Antonio Texas
Not listed The Woodlands Texas
Not listed Orem Utah
Not listed Salt Lake City Utah
Not listed Kirkland Washington
Not listed Seattle Washington
Not listed Brown Deer Wisconsin
Not listed Milwaukee Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 30 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01564862, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 4, 2015 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01564862 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →